Evaluation of the efficacy of oral N- acetylcysteine in the treatment of vitiligo patients
Phase 3
Recruiting
- Conditions
- vitiligo disease.Vitiligo
- Registration Number
- IRCT20210729052013N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
People with generalized vitiligo who volunteer for NB-UVB phototherapy
Exclusion Criteria
Patients with focal or segmental vitiligo
Patients with other skin diseases
Patients with a history of gastrointestinal ulcers
Patients with photosensitivity
Patients who have received systemic or topical medication for 2 months
Pregnant and lactating women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vitiligo severity score. Timepoint: At the beginning of the study (before the intervention), 2 and 4 months after the start of treatment. Method of measurement: Vitiligo Extent Tensity Index (VETI) score, which its maximum value is 55.5.
- Secondary Outcome Measures
Name Time Method The patient's tolerance of the treatment. Timepoint: Measurement periods: 2 and 4 months after starting treatment. Method of measurement: At each visit, patients determine their tolerance by choosing one of the following options: 1. Yes 2. No.;The patient's satisfaction with the treatment. Timepoint: Measurement periods: 2 and 4 months after starting treatment. Method of measurement: At each visit, patients determine their level of satisfaction by choosing one of the following options: 1. No 2. A little 3. Moderate 4. Good 5. Excellent.